Dr Brendon Chua’s research is centered on the design and development of experimental vaccine delivery systems and interventions to improve protective immunity against infectious diseases. He completed his PhD at The University of Melbourne and has held research positions at Monash University and with the CRC for Polymers. As a translational researcher, his work has often involved engagement with industrial partners and his studies on Toll-like receptor 2 agonist-based vaccines against chronic Hepatitis C and single-dose polymer-based vaccine depots against livestock diseases in particular, have led to Phase I clinical trial testing and large-scale vaccine trials. He is presently a CR Roper Research Fellow at The Peter Doherty Institute and an Assistant Professor of Hokkaido University, Japan as well as co-founder of Ena Therapeutics.
- Contact Details
Current Research Focus
Design and development of vaccine and therapeutic interventions, host protection against infectious diseases
Field of Research Description 110702 Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies) 110707 Innate Immunity
- Cell biology
- Flow cytometry
- Vaccine design
- Peptide chemistry
Looking to collaborate?
Neuroscience, metabolism, bioinformatics